Waters Corp

Chart & Performance

D1W1MN

P/E

34.63

P/S

7.52

EPS

10.82

Div Yield, %

0.00%

Shrs. gr., 5y

-5.25%

Rev. gr., 5y

4.09%

Revenues

2.96b

-0.52%

Net income

642m

-9.26%

CFO

603m

-1.45%

Dividend

Nov 26, 19960.16 USD/sh

Earnings

Feb 04, 2025

Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

URL

https://www.waters.com/

IPO date

Nov 17, 1995

Employees

8,200

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12	2014‑12
Income
Revenues	2,956,416 -0.52%	2,971,956 6.68%	2,785,874 17.78%
Cost of revenue	2,067,512	2,082,398	1,951,859
Unusual Expense (Income)
NOPBT	888,904	889,558	834,015
NOPBT Margin	30.07%	29.93%	29.94%
Operating Taxes	94,009	130,091	113,350
Tax Rate	10.58%	14.62%	13.59%
NOPAT	794,895	759,467	720,665
Net income	642,234 -9.26%	707,755 2.15%	692,843 32.84%
Dividends
Dividend yield
Proceeds from repurchase of equity	(70,277)	(583,260)	(593,287)
BB yield	0.36%	2.82%	2.57%
Debt
Debt current	105,650	76,429	27,906
Long-term debt	2,451,190	1,663,415	1,601,399
Deferred revenue		57,000	46,000
Other long-term liabilities	322,494	1,202,087	1,213,508
Net debt	2,156,031	1,239,290	1,060,020
Cash flow
Cash from operating activities	602,809	611,661	747,274
CAPEX	(160,632)	(183,456)	(168,266)
Cash from investing activities	(1,442,265)	(107,967)	(231,630)
Cash from financing activities	754,951	(509,633)	(438,275)
FCF	433,432	559,014	590,368
Balance
Cash	395,974	481,391	569,285
Long term investments	4,835	19,163
Excess cash	252,988	351,956	429,991
Stockholders' equity	9,018,328	8,368,639	7,690,588
Invested Capital	3,689,936	2,144,644	1,997,061
ROIC	27.25%	36.67%	37.43%
ROCE	22.54%	36.46%	35.03%
EV
Common stock shares outstanding	59,270	60,331	62,028
Price	329.23 -3.90%	342.58 -8.06%	372.60 50.59%
Market cap	19,513,462 -5.59%	20,668,194 -10.57%	23,111,633 49.66%
EV	21,669,493	21,907,484	24,171,653
EBITDA	1,054,809	1,019,981	965,695
EV/EBITDA	20.54	21.48	25.03
Interest	98,861	37,777	32,717
Interest/NOPBT	11.12%	4.25%	3.92%